Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) just unveiled an update.
Recce Pharmaceuticals Ltd. announced a $5 million placement to an Australian private investor and a pro-rata non-renounceable entitlement offer to raise approximately $10.8 million. The capital raising initiatives are expected to affect shareholder control dynamics, with potential dilution for existing shareholders due to the placement and entitlement offer.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development of synthetic anti-infectives. The company is known for its innovative approach to addressing antibiotic resistance and infections.
YTD Price Performance: -28.12%
Average Trading Volume: 184,492
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$76.52M
For a thorough assessment of RCE stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue